Reducing the Rebate Amount for Part D Rebatable Drugs in Shortage and When There Is a Severe Supply Chain Disruption or Likely Shortage ( 428.300 Through 428.303) Section 1860D-14B(b)(1)(C) of the Act requires the Secretary to reduce or waive the rebate amount owed by a manufacturer for a Part D rebatable drug with respect to an applicable period in three distinct cases: (1) when a Part D rebatable drug is described as currently in shortage on a shortage list in effect under section 506E of the FD&C Act at any point during the applicable period
Next, the relative abundance of metabolites associated with the TCA cycle and glycolysis across the three groups was determined
Psychological interventions for post-traumatic stress disorder in refugees and asylum seekers: A systematic review and meta-analysis
It can replace energy drinks, breath mints, gum, water flavor enhancers, cigarettes, snacks and more
Personal habits and indoor combustions
Archived from the original on January 22, 2009.